Modifier genes and Lynch syndrome: some considerations

Abstract Lynch Syndrome (LS) is a highly variable entity with some patients presenting at very young ages with malignancy whereas others may never develop a malignancy yet carry an unequivocal genetic predisposition to disease. The most frequent LS malignancy remains colorectal cancer, a disease tha...

Full description

Bibliographic Details
Main Author: Rodney J. Scott
Format: Article
Language:English
Published: BMC 2022-09-01
Series:Hereditary Cancer in Clinical Practice
Subjects:
Online Access:https://doi.org/10.1186/s13053-022-00240-2
_version_ 1811273814621814784
author Rodney J. Scott
author_facet Rodney J. Scott
author_sort Rodney J. Scott
collection DOAJ
description Abstract Lynch Syndrome (LS) is a highly variable entity with some patients presenting at very young ages with malignancy whereas others may never develop a malignancy yet carry an unequivocal genetic predisposition to disease. The most frequent LS malignancy remains colorectal cancer, a disease that is thought to involve genetic as well as environmental factors in its aetiology. Environmental insults are undeniably associated with cancer risk, especially those imparted by such activities as smoking and excessive alcohol consumption. Notwithstanding, in an inherited predisposition the expected exposures to an environmental insult are considered to be complex and require knowledge about the respective exposure and how it might interact with a genetic predisposition. Typically, smoking is one of the major confounders when considering environmental factors that can influence disease expression on a background of significant genetic risk. In addition to environmental triggers, the risk of developing a malignancy for people carrying an inherited predisposition to disease can be influenced by additional genetic factors that do not necessarily segregate with a disease predisposition allele. The purpose of this review is to examine the current state of modifier gene detection in people with a genetic predisposition to develop LS and present some data that supports the notion that modifier genes are gene specific thus explaining why some modifier gene studies have failed to identify associations when this is not taken into account.
first_indexed 2024-04-12T23:05:59Z
format Article
id doaj.art-b522d2a4fef046169cd1de1d3835f2c9
institution Directory Open Access Journal
issn 1897-4287
language English
last_indexed 2024-04-12T23:05:59Z
publishDate 2022-09-01
publisher BMC
record_format Article
series Hereditary Cancer in Clinical Practice
spelling doaj.art-b522d2a4fef046169cd1de1d3835f2c92022-12-22T03:12:55ZengBMCHereditary Cancer in Clinical Practice1897-42872022-09-012011410.1186/s13053-022-00240-2Modifier genes and Lynch syndrome: some considerationsRodney J. Scott0Discipline of Medical Genetics, School of Biomedical Sciences and Pharmacy, University of NewcastleAbstract Lynch Syndrome (LS) is a highly variable entity with some patients presenting at very young ages with malignancy whereas others may never develop a malignancy yet carry an unequivocal genetic predisposition to disease. The most frequent LS malignancy remains colorectal cancer, a disease that is thought to involve genetic as well as environmental factors in its aetiology. Environmental insults are undeniably associated with cancer risk, especially those imparted by such activities as smoking and excessive alcohol consumption. Notwithstanding, in an inherited predisposition the expected exposures to an environmental insult are considered to be complex and require knowledge about the respective exposure and how it might interact with a genetic predisposition. Typically, smoking is one of the major confounders when considering environmental factors that can influence disease expression on a background of significant genetic risk. In addition to environmental triggers, the risk of developing a malignancy for people carrying an inherited predisposition to disease can be influenced by additional genetic factors that do not necessarily segregate with a disease predisposition allele. The purpose of this review is to examine the current state of modifier gene detection in people with a genetic predisposition to develop LS and present some data that supports the notion that modifier genes are gene specific thus explaining why some modifier gene studies have failed to identify associations when this is not taken into account.https://doi.org/10.1186/s13053-022-00240-2Lynch syndromeMSH2MLH1Modifier genesIncidenceSurvival
spellingShingle Rodney J. Scott
Modifier genes and Lynch syndrome: some considerations
Hereditary Cancer in Clinical Practice
Lynch syndrome
MSH2
MLH1
Modifier genes
Incidence
Survival
title Modifier genes and Lynch syndrome: some considerations
title_full Modifier genes and Lynch syndrome: some considerations
title_fullStr Modifier genes and Lynch syndrome: some considerations
title_full_unstemmed Modifier genes and Lynch syndrome: some considerations
title_short Modifier genes and Lynch syndrome: some considerations
title_sort modifier genes and lynch syndrome some considerations
topic Lynch syndrome
MSH2
MLH1
Modifier genes
Incidence
Survival
url https://doi.org/10.1186/s13053-022-00240-2
work_keys_str_mv AT rodneyjscott modifiergenesandlynchsyndromesomeconsiderations